Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2-Reference-Cited by-同舟云学术

Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2

Published:2022-05 Issue: Volume:108-109 Page:61-69
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Ma Li,Grant Cameron,Gallazzi Fabio,Watkinson Lisa D.,Carmack Terry L.,Embree Mary F.,Smith C. Jeff,Medvedev Dmitri,Cutler Cathy S.,Li Yawen,Wilbur D. Scott,Hennkens Heather M.,Jurisson Silvia S.

Funder

US Department of Energy Office of Science

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference34 articles.

1. Radioarsenic: a promising theragnostic candidate for nuclear medicine;Sanders;Nucl Med Biol,2021

2. High yield production and radiochemical isolation of isotopically pure arsenic-72 and novel radioarsenic labeling strategies for the development of theranostic radiopharmaceuticals;Ellison;Bioconjug Chem,2016

3. Radioarsenic from a portable 72Se/72As generator: a current perspective;Ballard;Curr Radiopharm,2012

4. Chromatographic separation of selenium and arsenic: a potential 72Se/72As generator;Wycoff;J Chromatogr A,2014

5. Novel radiochemical separation of arsenic from selenium for 72Se/ 72As generator;Chajduk;Appl Radiat Isot,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management;PET Clinics;2024-07

2. Radiochemistry: A Hot Field with Opportunities for Cool Chemistry;ACS Central Science;2023-11-14

3. Medicinal inorganic chemistry – challenges, opportunities and guidelines to develop the next generation of radioactive, photoactivated and active site inhibiting metal-based medicines;Chemical Society Reviews;2022